Main Article Content
stability studies were conducted as per the International Conference on Harmonization (ICH) guidelines, and did not show
any degradation of the drug.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
Barry BW. Novel mechanisms and devices to enable successful
transdermal drug delivery. Eur J. Pharm Sci 2001;14:101-14.
Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug
Deliv Rev 2004;56:581-87.
Schuetz YB, Naik A, Emerging strategies for the transdermal delivery
of peptide and protein drugs. Expert Opin Drug Deliv 2005;2:533-48.
Memisoglu-Bilensoy E, Vural I, Bochot A, Renoir JM, Duchene D,
HÄ±ncal AA. Tamoxifen citrate loaded amphiphilic Î²-cyclodextrin
nanoparticles: In vitro characterization and cytotoxicity. J Control
Gao S, Singh J. In vitro percutaneous absorption enhancement of a
lipophilic drug tamoxifen by terpenes. J Control Release 1998;51:193-199.
Shin S, Choi J, Li X. Enhanced bioavailability of tamoxifen after
oral administration of tamoxifen with quercetin in rats. Int J Pharm
Arora P, Mukherjee B. Design, development, physicochemical and
in vitro and in vivo evaluation of transdermal patches containing
diclofenac diethyl ammonium salt. J Pharm Sci 2002;91:2076-89.
Wade Hull MS. Heat-enhanced transdermal drug delivery: A survey
paper. J Appl Res 2002;2:1-9.
Indian pharmacopoeia.2007. Ministry of Health and Family Welfare
Government of India, 2007. p. 1779.
Ritschel WA, Hussain AS. The principles of permeation of substance
across the skin. Methods Find. Exp Clin Pharmacol 1988;10:39-56.
Kaidi Z, Singh J. In vitro percutaneous absorption enhancement of
propranolol hydrochloride through porcine epidermis by terpenes /
ethanol. J Control Release 1999;62:359-66.
Rowe RC, Sheskery PJ. Weller PJ. Hand book of pharmaceutical excipient,
th ed. London: Pharmaceutical Press Publishers; 2003. P. 2115.
Mutalik S, Udupa N. Glibenclamide transdermal patches:physicochemical,
pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci
Mukherjee B, Mahapatra S, Gupta R, Patra B, Tiwari A, Arora P.
A comparison of povidone-ethylcellilose and povidone-eidragit
transdermal dexamethasone matrix patches based on in vitro skin
permeation. Eur J Pharm Biopharm 2005;59:475-483.
Ubaidulla U, Reddy MVS, Ruckmani K, Ahmad FJ, Khar RP. Transdermal
therapeutic system of carvedilol: effect of hydrophilic and hydrophobic
matrix on in vitro and in vivo characteristics. AAPS PharmSciTech
Sadashivaiah R, Dinesh BM, Desai BG, Raghu KS. Design and in vitro
evaluation of halperidol lactate transdermal patches containing ethyl
cellulose-povidone as film formers. Asian J Pharm 2008;4:43-49.
Limpongsa E, Umprayn K. Preparation and evaluation of diltiazem
hydrochloride diffusion-controlled transdermal delivery system. AAPS
Fischer W, Klokkers K, Sendl-Lang, A. Transdermal system in the form of
a patch comprising a tamoxifen derivative. US Patent 5,904,939;1999.